Structure model of HTATIP2/TIP30. Serine-132, tyrosine-143 and lysine-147, which correspond to the catalytically active residues in SDRs and NADPH are shown. The a-helices E and F normally involved in a dimer interface are labelled (Baker et al., 2000) .
Protein
Description HTATIP2 includes isoform a and isoform b, both of which contain 242aa, and isoform c, 131aa. HTATIP2 can interact with the N-terminal trans-activation domain of HIV-tat directly as 30kDa Tat-interacting protein, to activate the HIV-1 promoter (Xiao et al., 1998) , and with an ERa-interacting coactivator CIA to repress the expression of c-myc (Jiang et al., 2004) . It is a member of the short-chain dehydrogenases/reductases (SDR) family (Baker et al., 2000) and have a cavity of NADPH binding site in its structure (El Omari et al., 2005) . HTATIP2 has Ser/Thr protein kinase activity, which can undergo autophosphorylation, and phosphorylates the heptapeptide repeats of the C-terminal domain of the largest RNA polymerase II subunit in a tat-dependent manner. HTATIP2 binds directly to the karyopherins of the importin beta family in a RanGTP-insensitive manner and associates with nucleoporins in vivo (King and Shtivelman, 2004) .
Expression
HTATIP2 is an evolutionary conserved gene that is expressed ubiquitously in human tissues, while it is down-expressed in many tumors tissues, such as prostate, colon, liver, lung and breast cancers (Hewitt et al., 2000; Jiang et al., 2007; Lee et al., 2004; Varambally et al., 2002) .
Localisation
HTATIP2 protein was found predominantly in the membrane and nuclear fractions but not in the particulate free cytoplasmic fraction (Whitman et al., 2000) .
Function
The HTATIP2 gene is a tumor susceptibility gene, which is associated with the suppression of metastasis in small cell lung cancer (SCLC) (Shtivelman, 1997) , hepatocarcinoma (Ito et al., 2003) . HTATIP2 interacts with an Estrogen Receptor alpha-interacting coactivator CIA (coactivator independent of AF-2 function), to repress the expression of c-myc gene, and also associated with ets-1 to inhibit osteopontin transcription in human hepatocellular carcinoma (Zhao et al., 2008b) . HTATIP2 forms a RanGTP-resistant complex with importins to inhibit nuclear import and induce apoptosis (King and Shtivelman, 2004) . HTATIP2 also induces apoptosis under oxidative stress through stabilization of p53 mRNA (Zhao et al., 2008a) .
Homology
HTATIP2 encodes a protein whose sequence is highly conserved in evolution, with homologous genes being present in Caenorhabditis elegans, Saccharomyces cerevisiae, Escherichia coli (Whitman et al., 2000) , Branchiostoma belcheri , and Mus musculus.
Mutations
Note HTATIP2 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells (Jiang et al., 2007) .
Somatic
There are two types of HTATIP2 mutation, G134V and R106H, in hepatocellular carcinoma specimens (Jiang et al., 2007) .
The red amino acids are mutated into other one, as schematic representation (Jiang et al., 2007) .
Implicated in

Various carcinomas
Disease HTATIP2 reported to be down-regulated in some kinds of cancers, such as lung cancer (NicAmhlaoibh and Shtivelman, 2001 ), hepato-cellular carcinoma , gastric cancer (Li et al., 2009) , prostate cancer , breast carcinoma (Zhang et al., 2005; Zhao et al., 2007) .
Multiple sclerosis (MS)
Disease Oligodendrocyte precursor cells (OPCs) presist near the demyelinated axons arising in MS but inefficiently differentiate into oligodendrocytes and remyelinate these axons. Abnormal expression of HTATIP2, a direct inhibitor of Importin, is observed in these OPCs. Overexpression of HTATIP2 in a rat OPC cell line resulted in cytoplasmic entrapment of NICD and arrest of differentiation upon stimulation with Contactin-Fc.
